EMILY CUNNINGHAM-CARTER: Open Payments
NPI 1508460023 · ENUMCLAW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 34 payments from 8 companies in 2025. Trend: 2023 $68 · 2024 $576 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $221 |
| Incyte Corporation | 4 | $87 |
| GENZYME CORPORATION | 2 | $71 |
| Amgen Inc. | 2 | $35 |
| LEO Pharma Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| UCB, Inc. | 1 | $14 |
| Organon LLC | 1 | $8 |
Products named: SKYRIZI, RINVOQ, OPZELURA, DUPIXENT, OTEZLA, ANZUPGO, Bimzelx, VTAMA.
Industry payments across WA — which companies pay providers there.
